Literature DB >> 12184917

A new assay system for guinea pig interferon biological activity.

Toshiko Yamamoto1, Amminikutty Jeevan, Kazue Ohishi, Yasuhiro Nojima, Kiyoko Umemori, Saburo Yamamoto, David N McMurray.   

Abstract

We have developed an assay system for guinea pig interferon (IFN) based on reduction of viral cytopathic effect (CPE) in various cell lines. CPE inhibition was detected optimally in the guinea pig fibroblast cell line 104C1 infected with encephalomyocarditis virus (EMCV). The amount of biologically active guinea pig IFN was quantified by estimating viable cell numbers colorimetrically by means of a tetrazolium compound, 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt (WST-1) and 1-methoxy-5-methylphenazinium methylsulfate (PMS). WST-1 color developed until stopped by the addition of sulfuric acid. This had no effect on the colorimetric assay, and the color was stable for at least 24 h. The acid also inactivated the EMCV and, thus, eliminated the viral hazard. Inhibition of CPE activity was highly correlated with the concentration of culture supernatants from BCG-vaccinated guinea pig splenocytes stimulated in vitro with tuberculin or an immunostimulatory oligoDNA. This assay detected guinea pig IFN and human IFN-alpha, but not IFN-gamma from human, mouse, rat, pig, or dog. This assay system has proved useful for the titration of guinea pig IFN, being easy to perform, free from viral hazard, relatively species specific, highly reproducible, and inexpensive.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12184917     DOI: 10.1089/107999002320271387

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  7 in total

1.  Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation.

Authors:  A Jeevan; C T McFarland; T Yoshimura; T Skwor; H Cho; T Lasco; D N McMurray
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Development of a guinea pig immune response-related microarray and its use to define the host response following Mycobacterium bovis BCG vaccination.

Authors:  Julia A Tree; Michael J Elmore; Sajid Javed; Ann Williams; Philip D Marsh
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

3.  Effect of neutralizing transforming growth factor beta1 on the immune response against Mycobacterium tuberculosis in guinea pigs.

Authors:  Shannon Sedberry Allen; Lynne Cassone; Todd M Lasco; David N McMurray
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

4.  Coordinate cytokine gene expression in vivo following induction of tuberculous pleurisy in guinea pigs.

Authors:  Shannon Sedberry Allen; David N McMurray
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

5.  Lung macrophages from bacille Calmette-Guérin-vaccinated guinea pigs suppress T cell proliferation but restrict intracellular growth of M. tuberculosis after recombinant guinea pig interferon-gamma activation.

Authors:  A Jeevan; K Majorov; K Sawant; H Cho; D N McMurray
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

Review 6.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

7.  Evaluation of cell viability dyes in antiviral assays with RNA viruses that exhibit different cytopathogenic properties.

Authors:  Donald F Smee; Brett L Hurst; W Joseph Evans; Nathan Clyde; Sean Wright; Christopher Peterson; Kie-Hoon Jung; Craig W Day
Journal:  J Virol Methods       Date:  2017-03-27       Impact factor: 2.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.